Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients-Reference-Cited by-同舟云学术

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients

Published:2016-10 Issue:4 Volume:21 Page:377-391
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Panza Francesco,Seripa Davide,Solfrizzi Vincenzo,Imbimbo Bruno P.,Lozupone Madia,Leo Antonio,Sardone Rodolfo,Gagliardi Gaetano,Lofano Lucia,Creanza Bianca C.,Bisceglia Paola,Daniele Antonio,Bellomo Antonello,Greco Antonio,Logroscino Giancarlo

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/14728214.2016.1241232

Reference127 articles.

1. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

2. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

3. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

4. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

5. Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s Disease: Cellular and Pharmacological Aspects;Geriatrics;2024-06-22

2. A Molecular Mechanism of Stress-Induced Alzheimer’s Disease; Part 1;Journal of Macromolecular Science, Part B;2023-07-05

3. Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery;Deciphering Drug Targets for Alzheimer’s Disease;2023

4. Neuroprotective Effect of the Mixture of Gastrodiae elata and Glycyrrhizae uralensis In Vitro;Applied Sciences;2022-12-23

5. Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study;Journal of Alzheimer's Disease;2022-05-17